Daré Bioscience, Inc. Completes Regulation A Offering

Daré Bioscience, Inc. has completed a closing of its previously announced Regulation A offering. The offering involved up to 4,854,000 units, each consisting of one share of Series A Convertible Preferred Stock and two warrants to purchase common stock, priced at $5.00 per unit. In this closing, the company issued 43,050 units, which include 43,050 shares of Series A Preferred Stock and warrants to purchase up to 86,100 shares of common stock. This offering is being conducted under a Form 1-A filing, which was qualified by the SEC on January 5, 2026. The terms of the Series A Preferred Stock and warrants were previously detailed in a Form 8-K filed on January 29, 2026.